Profil
Kazuo Yamamoto is currently the President & Representative Director at Immunas Pharma, Inc. since 2017.
He is also the Representative Director at Laboratoires OncoTherapy Science France SARL since 2014.
Previously, he worked as the Director, GM-Administration & IR Contact at OncoTherapy Science, Inc. from 2008 to 2014.
Aktive Positionen von Kazuo Yamamoto
| Unternehmen | Position | Beginn |
|---|---|---|
Immunas Pharma, Inc.
 Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Präsident | 01.02.2017 |
| Laboratoires OncoTherapy Science France SARL | Direktor/Vorstandsmitglied | 01.08.2014 |
Ehemalige bekannte Positionen von Kazuo Yamamoto
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
| Laboratoires OncoTherapy Science France SARL |
